Treat-to-target in PsA: methods and necessity

Treat-to-target in PsA: methods and necessity

With increasing recognition of the high burden and impact of psoriatic arthritis (PsA) and the growing number of therapeutic options, there has been an intensifying focus on treatment strategy in recent years. In 2015, the Tight Control of Psoriatic Arthritis study confirmed the clinical benefit of...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	Dures, E, Shepperd, S, Mukherjee, S, Robson, J, Vlaev, I, Walsh, N, Coates, LC
Formatua:	Journal article
Argitaratua:	BMJ Publishing Group 2020

Antzeko izenburuak

Mixed methods study of clinicians’ perspectives on barriers to implementation of treat to target in psoriatic arthritis
nork: Dures, E, et al.
Argitaratua: (2020)

What should be the primary target of ‘treat to target’ in PsA?
nork: Coates, L, et al.
Argitaratua: (2018)

Assessment of the many faces of PsA: single and composite measures in PsA clinical trials
nork: McGagh, D, et al.
Argitaratua: (2020)

How routine use of a treat to target approach in PsA might impact on clinical decision making
nork: Coates, L
Argitaratua: (2017)

Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PsA-1 and SELECT-PsA-2 trials assessed according to modified PsARC
nork: Coates, LC, et al.
Argitaratua: (2021)

Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PSA-1 and SELECT-PsA-2 trials assessed according to modified PsARC
nork: Coates, LC, et al.
Argitaratua: (2022)

Does treat to target or achieving remission improve radiographic outcome in psa?
nork: Coates, L, et al.
Argitaratua: (2016)

Ethical issues in a TwiCs study in early PsA
nork: Coates, L, et al.
Argitaratua: (2017)

Comparing the visual analogue scale (VAS) and the numerical rating scale (NRS) in patient reported outcomes in PsA
nork: Ye, W, et al.
Argitaratua: (2020)

Treat to target in PsA should focus on clinical measures. Response to: ‘DAPSA versus cDAPSA: do we need use CRP?’ by Gonçalves et al.
nork: Van Mens, L, et al.
Argitaratua: (2019)

Quality of life improvements in patients with PsA who achieve remission or low disease activity targets: results from two clinical trials of ixekizumab at three years of treatment
nork: Coates, LC, et al.
Argitaratua: (2021)

Treating to target in psoriatic arthritis: assessing real-world outcomes and optimising therapeutic strategy for adults with psoriatic arthritis—study protocol for the MONITOR-PsA study, a trials within cohorts study design
nork: Rombach, I, et al.
Argitaratua: (2021)

Sex-specific challenges in patients with psoriatic arthritis (PsA): preliminary results from a systematic literature review (SLR)
nork: Coates, LC, et al.
Argitaratua: (2021)

Value of RAPID3 in patients with PsA: results from the TICOPA and LOPAS II databases
nork: Coates, L, et al.
Argitaratua: (2017)

Design and rationale of the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA)
nork: Mease, P, et al.
Argitaratua: (2018)

Usage of C-reactive protein testing in the diagnosis and monitoring of psoriatic arthritis (PsA): results from a real-world survey in the USA and Europe
nork: Ogdie, A, et al.
Argitaratua: (2022)

Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial
nork: Helliwell, PS, et al.
Argitaratua: (2022)

Multi-domain effectiveness of guselkumab evaluated via composite indices through 1 year in patients with PsA and inadequate response to TNFi: post hoc analysis of COSMOS
nork: Gossec, L, et al.
Argitaratua: (2024)

Screening/referral strategies for the early recognition of psoriatic arthritis (PsA) among patients with psoriasis: results of a GRAPPA survey
nork: Song, K, et al.
Argitaratua: (2023)

What should be the primary target of "treat to target" in psoriatic arthritis?
nork: Coates, LC, et al.
Argitaratua: (2018)

Secukinumab improves physical function and quality of life and inhibits structural damage in patients with PsA with sustained remission or low disease activity: results from the 2-year phase 3 FUTURE 5 study
nork: Coates, LC, et al.
Argitaratua: (2023)

Guselkumab was more effective than secukinumab in patients with plaque psoriasis and the subset of patients with self-reported PsA in the randomised, double-blind, head-to-head comparison study ECLIPSE over 1 year
nork: Merola, JF, et al.
Argitaratua: (2020)

PSA is dead, long live PSA.
nork: Vickers, A, et al.
Argitaratua: (2012)

The Luxury of Necessity
nork: Bamberger, Jeanne
Argitaratua: (2004)

The nature of necessity
nork: Leftow, B
Argitaratua: (2017)

Essence and Necessity
nork: Ditter, Andreas
Argitaratua: (2022)

On the necessity of the categories
nork: Gomes, A, et al.
Argitaratua: (2022)

Blood levels of free-PSA but not complex-PSA significantly correlates to prostate release of PSA in semen in young men, while blood levels of complex-PSA, but not free-PSA increase with age.
nork: Sävblom, C, et al.
Argitaratua: (2005)

Revolution : tragic necessity /
nork: 447211 Kly, Y. N.
Argitaratua: (1984)

Genetic correction of PSA values using sequence variants associated with PSA levels.
nork: Gudmundsson, J, et al.
Argitaratua: (2010)

Controversies in PSA screening
nork: O'Sullivan, J
Argitaratua: (2017)

Considers necessity in inoculation
nork: China Press
Argitaratua: (2020)

Fine-tuned of necessity?
nork: Page, BT
Argitaratua: (2018)

The paradox of medical necessity
nork: Godwin, S, et al.
Argitaratua: (2023)

What is ‘medical necessity’?
nork: Wilkinson, DJC
Argitaratua: (2023)

Necessity in international law
nork: Manton, R
Argitaratua: (2016)

Necessity and other-defence
nork: Eggert, L
Argitaratua: (2024)

Content and face validity and feasibility of 5 candidate instruments for psoriatic arthritis randomized controlled trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting
nork: Holland, R, et al.
Argitaratua: (2018)

Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: A community study
nork: Daugla, D, et al.
Argitaratua: (2013)

Association between polymorphisms in the prostate-specific antigen (PSA) promoter and release of PSA.
nork: Sävblom, C, et al.
Argitaratua: (2009)